Fankhauser, C. D., Sander, S., Roth, L., Gross, O., Eberli, D., Sulser, T., . . . Hermanns, T. (2018). Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy. Br J Cancer.

Fankhauser, Christian Daniel, Sophia Sander, Lisa Roth, Oliver Gross, Daniel Eberli, Tullio Sulser, Burkhardt Seifert, Joerg Beyer, and Thomas Hermanns. "Systemic Inflammatory Markers Have Independent Prognostic Value in Patients With Metastatic Testicular Germ Cell Tumours Undergoing First-line Chemotherapy." Br J Cancer 2018.

Fankhauser, Christian Daniel, et al. "Systemic Inflammatory Markers Have Independent Prognostic Value in Patients With Metastatic Testicular Germ Cell Tumours Undergoing First-line Chemotherapy." Br J Cancer 2018.